Passage BIO, Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

Q: Sep 30 2021

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Termination of a Material Definitive Agreement

Submission of Matters to a Vote of Security Holders

Cost Associated with Exit or Disposal Activities

Regulation FD Disclosure

Termination of a Material Definitive Agreement

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Results of Operations and Financial Condition

Other Events

Material Modifications to Rights of Security Holders

Other Events

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Results of Operations and Financial Condition

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933 (amendment)

Written communication about a business combination transaction (Rule 425)

Registration statement under Securities Act of 1933 (amendment)

Written communication about a business combination transaction (Rule 425)

Registration statement under Securities Act of 1933

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Post-effective amendment to a registration statement

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Post-effective amendment to a registration statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Vestal Point Capital, LP

Lynx1 Capital Management LP

Nichols Weston; Lynx1 Capital Management LP

Baselake Partners, LP

Countouriotis Athena

Sondhi Dolan

Porter Derrell

Kapadia Sandip

GOWEN MAXINE

Kassberg Thomas Richard

Chou William

Borthwick Kathleen

Chou William

Borthwick Kathleen

Chou William

Chou William

Borthwick Kathleen

Lynx1 Capital Management LP

Nichols Weston; Lynx1 Capital Management LP

ORBIMED ADVISORS LLC

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Correspondence with the SEC

Annual Report Scanned (Paper)

Letter from the SEC

Annual Report Scanned (Paper)

Post-effective amendment to an automatic shelf registration statement

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Draft registration statement (confidential submission)

No description available

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

No description available

No description available

No description available

Draft registration statement (confidential submission) (amendment)

Letter from the SEC